FOI 25-0299 LD – Baby Formula Products At WHA 2025

Written by Claude Haiku 4.5 from the extracted text on 27 Feb 2026. It can miss or misread redacted and scanned pages. Check the source before relying on it.

This FOI disclosure contains Australian Government briefing materials for the 2025 World Health Assembly, focusing on proposed WHO resolutions regarding breast-milk substitutes regulation. A finalised resolution led by Brazil, Mexico, and 15 other countries seeks to regulate digital marketing of breast-milk substitutes globally. The Department of Health and Aged Care assessed this proposal, noting that global ambitions appear to broaden regulatory scope beyond Australia's current frameworks. The document also references the 156th WHO Executive Board session agenda item on the Global Strategy for Women's, Children's and Adolescents' Health, which will consider two resolutions on breast-milk substitutes. Much of the document content was redacted under section 22 of the Freedom of Information Act. The disclosure provides limited substantive detail on Australia's position or specific regulatory concerns regarding infant formula marketing standards.